FDA clearance for Binax Bacterial Meningitis

Binax have announced an additional cleared application for the patented Streptococcus pneumoniae Antigen Test.

The test can be used on CSF for the detection of bacterial meningitis caused by S. pneumoniae

Binax recently announced an exclusive distribution partnership with Remel Inc to provide rapid tests to hospital and clinical reference laboratories in the USA.


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Binax, Inc. [USA]
Now part of Alere, Inc View Company Information

Posted on December 15, 2001








Get our eNewsletter
Over 6,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS